Using MRI-guided biopsies to diagnose prostate cancer with high accuracy

Many prostate cancer patients — and particularly those who don’t like the idea of prostate biopsies — think that if one uses MRI-guided biopsies alone one might only need to have one or two biopsy cores taken to accurately diagnose prostate cancer. … READ MORE …

mpMRIs, MRI/TRUS fusion-guided biopsies, and systematic biopsies in monitoring of men on active surveillance

A new article in the Journal of Urology has provided us with some initial insight into the value of multiparametric MRIs (mpMRIs) in monitoring progression of patients on active surveillance protocols. … READ MORE …

Targeted biopsy processes alone are not good enough for accurate diagnosis

A significant number of patients have wanted to believe that, with the coming of targeted biopsies based on multiparametric MRI imaging, the need for “random” systematic biopsies (e.g., standard 10- or 12-core biopsies) would go away. … READ MORE …

MRI/TRUS fusion-guided biopsies and the diagnosis of prostate cancer

An important article by Siddiqui et al. appears in this week’s issue of the Journal of the American Medical Association. It deals with the experience of Dr. Peter Pinto and his colleagues in the diagnosis of prostate cancer in about 1,000 patients over the past few years. … READ MORE …

MRI/TRUS fusion-guided biopsy in a community-like urology practice

A new study just reported in the Journal of Urology provides information on the application of MRI/TRUS fusion-guided prostate biopsy to diagnose prostate cancer in a community-like urology practice (as opposed to a major prostate cancer research center). … READ MORE …